News from WCM

Messenger RNAs (mRNAs) contain chemical marks that are critical for antiviral defense in cells.

Dr. Asad Siddiqi has been named chief of the Department of Physical Medicine and Rehabilitation at NewYork-Presbyterian Brooklyn Methodist Hospital. 

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells.

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack.

The National Institute on Aging of the National Institutes of Health has awarded a grant to Weill Cornell Medicine to develop a screening tool and intervention for elder neglect in patients with Alzheimer’s disease and related dementias.

More than 160 faculty and students filled Uris Auditorium Dec. 5 to hear doctoral candidates deliver bite-size presentations of their research in an entertaining way. The catch? They had to deliver their work in three minutes or less.

A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution.

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells.

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes.

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models.

The long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals compared with non-pregnant individuals of reproductive age.

Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study whether the antibiotic doxycycline may slow the progression of the chronic lung disease emphysema in people living with well-controlled HIV.

Acinetobacter pittii (A. pittii), a type of bacteria, is evolving to become more resistant to antibiotics and is finding ways to survive in the harsh environment of the International Space Station.

A Medicare system that is meant to assess and incentivize healthcare quality with pay adjustments may not be working as intended, according to a study from researchers at Weill Cornell Medicine.

The Medicaid program allocates nearly $20 billion a year in subsidies to support safety-net hospitals and other health care providers that serve low-income patients. 

Dr. Sandhya K. Balaram, a leading adult cardiac surgeon in New York City, has been named chief of the Department of Cardiothoracic Surgery at NewYork-Presbyterian Brooklyn Methodist Hospital.

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University, plans to return to his research at the end of the calendar year, following his tenure as dean. In this Q&A, Dr. Choi discusses the ways the institution had evolved under his six years of leadership.

In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 during infancy in pre-clinical research.

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease.